Condition

Multiple Sclerosis (MS) Secondary Progressive

ClinicalTrials.gov condition label

Clinical trials9

Recruiting5

Common interventions12

Lead sponsors shown9

Clinical trials

9 shown

Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple SclerosisNCT07587125 · 2026-05-08

Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisNCT07477639 · 2026-03-01

Home Based Functional Balance Intervention for Multiple SclerosisNCT07355387 · 2025-11-24

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSNCT07222618 · 2025-10-01

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesNCT07085676 · 2024-09-01

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNCT07222956 · 2027-03-01

NOT_YET_RECRUITING

Acute Intermittent Hypoxia Combined With Gait Training in Multiple SclerosisNCT07631923 · 2026-06-15

NOT_YET_RECRUITING

Senolytics for Secondary Progressive MSNCT07270120 · 2026-01-15

NOT_YET_RECRUITING

Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculographyNCT04705610 · 2017-05-23

Common interventions

Acute Intermittent Hypoxia (AIH)OTHER1 BendamustineDRUG1 Dasatinib and quercetinDRUG1 HBI0101 CARTBIOLOGICAL1 Multicomponent balance intervention consisting of four components including dual-tasking, functional strength, vestibular and dynamic balance.BEHAVIORAL1 Myoelectric Interface Neurorehabilitation Training (MINT)OTHER1 Remibrutinib (Open Label)DRUG1 S103 cellsDRUG1 Sham Acute Intermittent Hypoxia (AIH)OTHER1 StretchingBEHAVIORAL1 TRX319BIOLOGICAL1 Video-oculography / Social cognition tasks / Neuropsychological evaluationsOTHER1

Leading sponsors

Association de Recherche Bibliographique pour les Neurosciences1 Moein Amin1 Ohio State University1 Polina Stepensky1 Shirley Ryan AbilityLab1 Tr1X, Inc.1 University of California, San Francisco1 University of Illinois at Chicago1 Xijing Hospital1

Trial status mix

RECRUITING5

NOT_YET_RECRUITING3

COMPLETED1

Phase mix

PHASE14

NA3

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.